SPC
CL icon

Salient Private Client’s Colgate-Palmolive CL Stock Holding History

Salient Private Client’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$6.79M Sell
101,398
-918
-0.9% -$61.1K 1.32% 21
2018
Q2 		$6.63M Sell
102,316
-8,352
-8% -$546K 1.12% 25
2018
Q1 		$7.93M Buy
110,668
+3,037
+3% +$219K 1.39% 19
2017
Q4 		$8.12M Buy
+107,631
New +$7.86M 1.67% 14

Other funds holding CL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Salient Private Client's CL Position: Q3 2018 in Review

Salient Private Client reduced its Colgate-Palmolive (CL) stake by 0.9% in Q3 2018, selling an estimated $61.1K and leaving 101,398 shares worth $6.79M. The position accounts for 1.32% of the portfolio, ranked #21.

Salient Private Client first reported a position in CL in Q4 2017 and has held it in 4 quarters since. The position peaked at $8.12M in Q4 2017. 1,393 funds tracked by Wall St. Rank hold CL as of Q3 2018.

  • Salient Private Client held 101,398 shares of Colgate-Palmolive worth $6.79M as of Q3 2018.
  • Salient Private Client sold 918 Colgate-Palmolive shares in Q3 2018, an estimated $61.1K.
  • Colgate-Palmolive made up 1.32% of Salient Private Client's portfolio in Q3 2018, its #21 holding.
  • Salient Private Client first reported a position in Colgate-Palmolive in Q4 2017 and has held it in 4 quarters since.
  • Salient Private Client's Colgate-Palmolive position peaked at $8.12M in Q4 2017.
  • 1,393 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2018.

Based on Salient Private Client's 13F filing for Q3 2018, filed 14 Nov 2018.